Phase 4 authority hub

Vaginal & Urinary Health Medication Guides

Compare vaginal estradiol products, estrogen creams, prasterone, ospemifene, recurrent UTI prevention, and cost or insurance questions.

Last reviewed: August 26, 2026 · Medical reviewer not yet assigned

Vaginal and urinary health treatment consultation

Direct answer: Local vaginal therapy includes estradiol inserts, rings, creams, conjugated-estrogen cream, and non-estrogen options such as prasterone. Current urology guidance also recommends low-dose vaginal estrogen for eligible perimenopausal and postmenopausal women with recurrent UTIs.

Medical safety: Vaginal and urinary symptoms can have causes other than menopause, including infection, dermatologic disease, pelvic-floor disorders, bleeding disorders, and malignancy. New or unexplained postmenopausal bleeding, persistent urinary symptoms, fever, flank pain, or severe pain needs clinical evaluation. Do not start or switch prescription therapy without a licensed clinician.

Choose the decision you are making

Vagifem vs Estring

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Imvexxy vs Vagifem

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Imvexxy vs Estring

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Premarin Vaginal Cream vs Estradiol Cream

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Estradiol Cream vs Estring

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Vagifem vs Premarin Vaginal Cream

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Vaginal Estrogen for Recurrent UTI Prevention

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Vaginal vs Systemic Estrogen for Recurrent UTI Prevention

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Vagifem Cost Without Insurance

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Imvexxy Cost Without Insurance

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Estring Cost Without Insurance

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Premarin Vaginal Cream Cost Without Insurance

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Intrarosa vs Vaginal Estrogen

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Intrarosa vs Imvexxy

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Osphena vs Vaginal Estrogen

Decision-focused comparison covering formulation, guidance, safety, cost, and access.

Why recurrent UTI belongs in this hub

The 2025 AUA recurrent UTI guideline recommends vaginal estrogen for eligible perimenopausal and postmenopausal women to reduce future UTI risk and specifically distinguishes it from systemic estrogen.

Primary and clinical sources

Sources checked August 26, 2026. Labels, coverage and clinical guidance can change.